Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Elicera Therapeutics
Tag: Elicera Therapeutics
Elicera receives funding for clinical trials with ELC-301
3 June, 2022
Elicera continues to deliver proof-of-concept data
29 April, 2022
BioStock Studio: Elicera’s immuno-oncology platform iTANK reaches high-impact journal
6 April, 2022
Elicera well-positioned to thrive in 2022
20 January, 2022
Elicera Therapeutics partners with Baylor College of Medicine
17 December, 2021
Elicera Therapeutics keeps strong momentum after IPO
24 November, 2021
Elicera Therapeutics enters agreement with BioNTech
12 November, 2021
Elicera Therapeutics’ iTANK-platform reaches proof-of-concept
20 October, 2021
Elicera Therapeutics comes out of the gate running in Q2
31 August, 2021
Successful new share issue provides tailwinds for Elicera Therapeutics
28 June, 2021
1
2
3
4
Page 3 of 4